INMD

InMode Ltd

INMD, USA

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

https://www.inmodemd.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
INMD
stock
INMD

InMode’s Shares Look Cheap—But Caution Remains For 2025 Finimize

Read more →
INMD
stock
INMD

InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In (NASDAQ:INMD) Seeking Alpha

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$16.8

Analyst Picks

Strong Buy

1

Buy

1

Hold

5

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

6.85

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Low

1.42

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

3.35 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

2.98 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

28.97 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.12

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 44.18% of the total shares of InMode Ltd

1.

Renaissance Technologies Corp

(3.6807%)

since

2025/06/30

2.

BlackRock Inc

(3.6304%)

since

2025/06/30

3.

Doma Perpetual Capital Management LLC

(3.5427%)

since

2025/06/30

4.

LSV Asset Management

(3.0677%)

since

2025/06/30

5.

Meitav Dash Investments Ltd

(2.0934%)

since

2025/06/30

6.

BTIM Corp

(2.0865%)

since

2025/06/30

7.

Millennium Management LLC

(1.9508%)

since

2025/06/30

8.

Systematic Financial Management LP

(1.726%)

since

2025/06/30

9.

Harel Insurance Invests & Fin Srvcs Ltd

(1.4238%)

since

2025/06/30

10.

Royal Bank of Canada

(1.3814%)

since

2025/06/30

11.

Bank of America Corp

(1.3641%)

since

2025/06/30

12.

JPMorgan Chase & Co

(1.3343%)

since

2025/06/30

13.

Hotchkis & Wiley Capital Management LLC

(1.294%)

since

2025/06/30

14.

Morgan Stanley - Brokerage Accounts

(1.2715%)

since

2025/06/30

15.

VOLORIDGE INVESTMENT MANAGEMENT, LLC

(1.1408%)

since

2025/06/30

16.

State Street Corp

(1.1211%)

since

2025/06/30

17.

North Growth Management Ltd

(1.0426%)

since

2025/06/30

18.

North Growth US Equity

(0.959%)

since

2025/06/30

19.

Edgestream Partners, L.P.

(0.9087%)

since

2025/06/30

20.

Marshall Wace Asset Management Ltd

(0.8789%)

since

2025/06/30

21.

Boston Trust Walden Small Cap

(0.8625%)

since

2025/07/31

22.

Jane Street Group LLC

(0.7836%)

since

2025/06/30

23.

iShares Core MSCI EAFE ETF

(0.7706%)

since

2025/08/31

24.

CWA Quant Alpha Small/Mid-Cap

(0.5506%)

since

2025/03/31

25.

JPMorgan Small Cap Blend A

(0.5422%)

since

2025/07/31

26.

JPM US Small Cap Value-Composite

(0.5349%)

since

2025/06/30

27.

Fidelity Small Cap America Sr B

(0.4744%)

since

2025/03/31

28.

Merchfondo FI

(0.4034%)

since

2025/08/31

29.

Hotchkis & Wiley Sm Cp Divers Val I

(0.3566%)

since

2025/07/31

30.

Merchbanc Global PP

(0.3481%)

since

2025/08/31

31.

State St Gbl Sm Cp Eq ex-US Indx NL Cl A

(0.2992%)

since

2025/08/31

32.

iShares Core MSCI Total Intl Stk ETF

(0.2928%)

since

2025/08/31

33.

Boston Trust Walden Small Cap CIT

(0.2909%)

since

2025/07/31

34.

Marathon Global Opportunities Equity

(0.2885%)

since

2025/06/30

35.

iShares MSCI EAFE Small-Cap ETF

(0.2793%)

since

2025/08/31

36.

Wasatch Micro Cap Value Composite

(0.261%)

since

2025/03/31

37.

AMG River Road Small Cap Value N

(0.2446%)

since

2025/07/31

38.

Merch-Universal FI

(0.2373%)

since

2025/08/31

39.

IG Mackenzie Global Health Care B

(0.236%)

since

2025/06/30

40.

Multi-Manager Small Cap Eq Strat Inst

(0.2284%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.42

Latest Release

Date

2025-09-30

EPS Actual

0.38

EPS Estimate

0.35

EPS Difference

0.03

Surprise Percent

8.5714%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(9)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(9.3)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(7)
Net Net
Possible Net-Net(4.5)
Quality
High Quality(8.5)
Value
Undervalued(9.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.